GENMAB A/S (GMXAY) earnings
Quarterly and annual GMXAY reports and results, each read against the price at its own news timestamp. Back to the GMXAY overview →
2 measured GMXAY earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Genmab Publishes 2025 Annual Report | Press release | -0.11% | -2.65% | |
| Genmab Publishes 2023 Annual Report | Press release | +0.11% | +1.92% |
Keep exploring
More GMXAY: analyst actions → · SEC filings → · GMXAY overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Synergy CHC Corp. (SNYR) | 126 | -0.06% | 43% |
| Accelerate Diagnostics, Inc. (AXDX) | 125 | -0.16% | 36% |
| BIOTRICITY INC (BTCY) | 124 | 0.00% | 38% |
| CLEMENTIA PHARMACEUTICALS INC COMMON SHARES (CMTA) | 124 | +0.03% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.